Paroxetine

Paroxetine is a phenylpiperidine-derivative selective serotonin reuptake inhibitor (SSRI) with the highest affinity for SERT among all SSRIs. It also exhibits mild anticholinergic and nitric oxide synthase-inhibiting properties. Prolonged-release formulation ensures gradual drug release over 24 hours, mitigating peak-related gastrointestinal and sedative adverse effects. Indicated for major depressive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and PTSD.

Clonazepam is a long-acting benzodiazepine with potent anticonvulsant, muscle-relaxant, and anxiolytic actions on the WHO Model List of Essential Medicines. It allosterically modulates GABAA receptors, increasing frequency of chloride channel opening and dampening epileptic foci in the cortex and limbic system. Indicated for panic disorder with or without agoraphobia, Lennox-Gastaut syndrome, myoclonic and akinetic seizures, and absence seizures refractory to succinimides.

Paroxetine is a phenylpiperidine-derivative selective serotonin reuptake inhibitor (SSRI) with the highest affinity for SERT among all SSRIs. It also exhibits mild anticholinergic and nitric oxide synthase-inhibiting properties. Prolonged-release formulation ensures gradual drug release over 24 hours, mitigating peak-related gastrointestinal and sedative adverse effects. Indicated for major depressive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and PTSD.

Paroxetine is a phenylpiperidine-derivative selective serotonin reuptake inhibitor (SSRI) with the highest affinity for SERT among all SSRIs. It also exhibits mild anticholinergic and nitric oxide synthase-inhibiting properties. Prolonged-release formulation ensures gradual drug release over 24 hours, mitigating peak-related gastrointestinal and sedative adverse effects. Indicated for major depressive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and PTSD.